FCER1A rs1140317: What Your Genotype Means
The rs1140317 variant is located within the FCER1A gene, which encodes the alpha subunit of the high-affinity IgE receptor. This receptor is a critical component of the immune system's allergic response, and variations in this gene have been associated with differences in total serum IgE concentrations and allergic sensitization.
What each genotype means
Typical IgE receptor profile
This genotype represents the most common configuration for this variant in many populations. Research indicates that the FCER1A gene is a susceptibility locus for total serum IgE levels, but the specific impact of this individual variant remains limited and requires further study to fully understand its role in allergic sensitization.
This is the most frequent genotype in European populations, where the minor allele frequency is approximately 0.35.
Intermediate IgE receptor profile
Carrying one copy of the minor allele may influence the expression or function of the high-affinity IgE receptor alpha subunit. While this gene is associated with allergic responses and IgE regulation, the clinical significance of this specific genotype is not fully established and should not be used to predict individual allergy risk.
This heterozygous genotype is common, appearing in a significant portion of individuals across European and East Asian ancestries.
Variant IgE receptor profile
This genotype contains two copies of the minor allele associated with the FCER1A gene. While this locus has been identified in genome-wide association studies as a factor in IgE regulation, the evidence linking this specific variant to clinical allergic disease is limited and mixed. Please discuss any concerns regarding allergy symptoms or IgE levels with your healthcare provider.
This genotype is less common, occurring in roughly 1 in 8 to 1 in 10 individuals of European ancestry, and is observed at lower frequencies in East Asian populations.
Understanding the rs1140317 Variant
The rs1140317 variant is a single nucleotide polymorphism (SNP) situated within the FCER1A gene on chromosome 1. In genetics, a SNP represents a variation at a single position in the DNA sequence among individuals. The FCER1A gene provides instructions for creating the alpha subunit of the high-affinity immunoglobulin E (IgE) receptor, known as FcεRI. This receptor is primarily found on the surface of mast cells and basophils, which are specialized immune cells. When IgE antibodies bind to allergens, they attach to these receptors, triggering the cells to release chemical mediators like histamine. This process is the fundamental mechanism behind immediate hypersensitivity reactions, commonly known as allergies. Because rs1140317 is located in a region associated with this receptor, researchers study it to understand how subtle genetic differences might influence the intensity of the immune system's response to environmental triggers.
The Role of FCER1A in Allergy
The FCER1A gene is essential for the proper function of the high-affinity IgE receptor. By forming the alpha subunit, the protein encoded by this gene acts as the primary binding site for IgE molecules. When multiple receptors are cross-linked by allergen-bound IgE, it initiates a signaling cascade that leads to the activation of mast cells and basophils. This activation results in the release of various inflammatory substances, including vasoactive amines and cytokines, which contribute to the symptoms of allergic conditions. Because of its central role in this pathway, the FCER1A gene has been a major focus of research into the genetic basis of atopic diseases. Variations in this gene are hypothesized to alter the expression or function of the receptor, potentially modulating an individual's susceptibility to allergic sensitization or the severity of their IgE-mediated immune responses.
Research and Evidence Strength
Scientific research has identified associations between variants in the FCER1A gene and total serum IgE levels, which are often elevated in individuals with allergies. Genome-wide association studies (GWAS) have highlighted the FCER1A region as a susceptibility locus for IgE-related traits. However, the evidence specifically linking rs1140317 to clinical outcomes is considered limited. While some studies have found significant correlations between FCER1A polymorphisms and IgE levels or allergic sensitization, these findings can be inconsistent across different populations. For instance, some studies in specific ethnic groups have failed to replicate associations found in others, suggesting that the impact of this variant may be influenced by genetic background or environmental factors. Consequently, while the biological pathway is well-understood, the clinical predictive power of this specific SNP remains a subject of ongoing investigation rather than a definitive diagnostic marker.
What This Information Means for You
It is important to understand that genetic variants like rs1140317 represent statistical associations observed in large population studies, not individual medical diagnoses. Having a particular genotype does not guarantee that you will develop allergies, nor does it mean you are immune to them. Allergic conditions are complex, resulting from a combination of multiple genetic factors and environmental exposures. If you are concerned about allergies or your immune health, this genetic information should not be used to make personal health decisions or to alter any medical treatments. Always consult with a qualified healthcare provider or an allergist to discuss your symptoms, medical history, and appropriate testing. If you are currently taking medications for allergies, do not change your dosage or treatment plan based on genetic data without first speaking with your clinician or pharmacist.
How common is this variant?
The minor allele frequency for rs1140317 is approximately 0.35 in European populations and 0.22 in East Asian populations.
Frequently asked questions
Does having the rs1140317 variant mean I have allergies?
No, having this variant does not mean you have allergies. It is a statistical marker associated with IgE levels in population studies, but allergies are complex conditions influenced by many genes and environmental factors.
Can I use this SNP to predict my risk of food allergies?
Current research does not support using this SNP as a predictive tool for food allergies. While the gene is involved in the allergic pathway, individual risk is determined by a wide range of factors beyond a single genetic variant.
Should I change my allergy medication based on my genotype?
No. You should never change your medication or dosage based on genetic test results. Always consult your doctor or pharmacist before making any changes to your prescribed treatment plan.
Why do different studies show different results for this gene?
Genetic associations can vary between populations due to differences in genetic background and environmental exposures. This is why some findings are replicated in certain groups but not in others.
Sources & further reading
Educational information only, last refreshed 10/14/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs1140317?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in FCER1A
Promoter-proximal variant regulating FCER1A transcriptional responsiveness during high-affinity IgE crosslinking on mast cells and basophils.
Regulatory variant in the high-affinity IgE receptor gene FCER1A modulating circulating total IgE concentrations and allergic manifestations.
Variant in the high-affinity IgE receptor alpha subunit locus influencing IgE receptor transcription and susceptibility to atopic allergic sensitization.
Functional FCER1A polymorphism in high linkage disequilibrium with IgE-associated loci that modulates basophil and mast cell IgE receptor expression.
Variant in the high-affinity IgE receptor alpha chain gene strongly associated with regulation of total serum IgE levels and allergic sensitization risk.